Log In
BCIQ
Print this Print this
 

Epicutaneous immunotherapy, Viaskin-OVA

  Manage Alerts
Collapse Summary General Information
Company DBV Technologies S.A.
DescriptionViaskin patch containing ovalbumin
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationCrohn's disease
Indication DetailsTreat Crohn's disease
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today